Stock info IDT Corp | Filter  Basic-Info

IDT Corp

The past year was a good year for IDT Corp investors

Over the past year the company' stock gained around 55 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 151 percent. IDT Corp's revenues between 2011 and 2015 were quite similar and moved between 1,51 billion dollars and 1,6 billion dollars. IDT Corp's net results between 2011 and 2015 were very fluctuating and moved between 19,87 million dollars and 86,12 million dollars.

IDT Corp mainly operates in the biotech sector. Over the past 10 years the global biotech companies gained around 59 percent. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-2016) there is a minus of 59 percent.

The American company paid out dividends in the past 5 years. On average the IDT Corp stock yielded a delivered a dividend yield of around 4,93 percent over the past 5 years.

IDT Corp financed with relatively low debt

At the end of 2015 the American company's balance sheet was worth 485,68 million dollars. 351,85 million dollars (72,44 percent of the total balance sheet) was financed by debt. The American company's price/earnings-ratio was 22. So the market valued the stock at 22 times the 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the biotech company's market size (her number of outstanding share times the stock price) equaled around 261,32 million dollars. At the end of 2015 the American company had around 22,9 million stocks listed.

All the company's financial reports are available here. More information about IDT Corp can be found it's website. .